This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NP002

Neuraltus Pharmaceuticals, Inc.

Drug Names(s): NP002

Description: NP002 is a small molecule, orally available nicotinic receptor agonist that has been shown in preclinical studies to reduce levodopa-induced dyskinesias (LIDs) without affecting Parkinsonian symptoms.


NP002 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug